Your browser doesn't support javascript.
loading
Insights Into PROM1-Macular Disease Using Multimodal Imaging.
Paavo, Maarjaliis; Lee, Winston; Parmann, Rait; Lima de Carvalho, Jose Ronaldo; Zernant, Jana; Tsang, Stephen H; Allikmets, Rando; Sparrow, Janet R.
Afiliação
  • Paavo M; Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
  • Lee W; Helsinki University Eye Hospital, Helsinki, Finland.
  • Parmann R; Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
  • Lima de Carvalho JR; Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
  • Zernant J; Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
  • Tsang SH; Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
  • Allikmets R; Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
  • Sparrow JR; Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States.
Invest Ophthalmol Vis Sci ; 64(4): 27, 2023 04 03.
Article em En | MEDLINE | ID: mdl-37093133
ABSTRACT

Purpose:

To describe the features of genetically confirmed PROM1-macular dystrophy in multimodal images.

Methods:

Thirty-six (36) eyes of 18 patients (5-66 years; mean age, 42.4 years) were prospectively studied by clinical examination and multimodal imaging. Short-wavelength autofluorescence (SW-AF) and quantitative fundus autofluorescence (qAF) images were acquired with a scanning laser ophthalmoscope (HRA+OCT, Heidelberg Engineering) modified by insertion of an internal autofluorescent reference. Further clinical testing included near-infrared autofluorescence (NIR-AF; HRA2, Heidelberg Engineering) with semiquantitative analysis, spectral domain-optical coherence tomography (HRA+OCT) and full-field electroretinography. All patients were genetically confirmed by exome sequencing.

Results:

All 18 patients presented with varying degrees of maculopathy. One family with individuals affected across two generations exhibited granular fleck-like deposits across the posterior pole. Areas of granular deposition in SW-AF and NIR-AF corresponded to intermittent loss of the ellipsoid zone, whereas discrete regions of hypoautofluorescence corresponded with a loss of outer retinal layers in spectral-domain optical coherence tomography scans. For 18 of the 20 eyes, qAF levels within the macula were within the 95% confidence intervals of healthy age-matched individuals; nor was the mean NIR-AF signal increased relative to healthy eyes.

Conclusions:

Although PROM1-macular dystrophy (Stargardt disease 4) can exhibit phenotypic overlap with recessive Stargardt disease, significantly increased SW-AF levels were not detected. As such, elevated bisretinoid lipofuscin may not be a feature of the pathophysiology of PROM1 disease. The qAF approach could serve as a method of early differential diagnosis and may help to identify appropriate disease targets as therapeutics become available to treat inherited retinal disease.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distrofias Retinianas / Degeneração Macular Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distrofias Retinianas / Degeneração Macular Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos